Daniel L. Alkon's Net Worth
$68.4 Thousand
Who is Daniel L. Alkon?
Daniel L. Alkon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Synaptogenix, Inc., and Neurotrope, Inc..
SEC CIK
Daniel L. Alkon's CIK is 0001686138
Past Insider Trading and Trends
2021 was Daniel L. Alkon's most active year for acquiring shares with 3 total transactions. Daniel L. Alkon's most active month to acquire stocks was the month of October. 2020 was Daniel L. Alkon's most active year for disposing of shares, totalling 6 transactions. Daniel L. Alkon's most active month to dispose stocks was the month of November. 2021 saw Daniel L. Alkon paying a total of $82,600.00 for 133,750 shares, this is the most they've acquired in one year. In 2022 Daniel L. Alkon cashed out on 19,688 shares for a total of $23,072.37, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Synaptogenix, Inc. (SNPX) Snapshot price: $3.6
President and CSODaniel L. Alkon owns 35,546 units of Common Stock, par value $0.0001 per share which is worth $127,965.60. In the year 2021 Daniel L. Alkon filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.64% | -19.69K |
$1.17 | -$23,072.37 | 35.55K |
Scheduled
|
Dec 16
| ||
Form 4/A
| +380.96% | 43.75K |
—
|
—
| 55.23K |
Jul 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
| +696.62% | 80K |
—
|
—
| 91.48K |
Jul 13
| |||
Form 4
| +673.85% | 10K |
$8.26 | $82,600.00 | 11.48K |
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neurotrope, Inc. No price found
See RemarksDaniel L. Alkon used to own units in Common Stock but no longer holds any shares there.disposed a total of 29,688 shares of Neurotrope, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -29.69K |
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||